-
摘要:
骨关节炎(osteoarthritis, OA)是中、老年人群中的常见病与多发病，发病率随年龄增长而大幅升高。如何更好地防治OA正越来越成为全社会关注的卫生保健问题。但目前骨关节炎的发病机制的不明确，不能有效阻止OA的进展。针对此问题，本文就骨关节炎的治疗靶点及相关的信号通路做一概述。
-
[1] De Ceuninck F, Caliez A, Dassencourt L, et al. Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytes [J]. Arthritis Res Ther, 2004, 6(5): R393-403. http://www.biomedcentral.com/content/download/xml/ar1201.xml [2] Goldring MB. Are bone morphogenetic proteins effective inducers of cartilage repair? Ex vivo transduction of muscle-derived stem cells [J]. Arthritis Rheum, 2006, 54(2): 387-9. doi: 10.1002/(ISSN)1529-0131 [3] Tang QO, Shakib K, Heliotis M, et al. TGFbeta3:A potential biological therapy for enhancing chondrogenesis[J]. Expert Opin Biol Ther, 2009, 9(6): 689-701. doi: 10.1517/14712590902936823 [4] Blaney DE, Vitters EL, van der Kraan PM, et al. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signaling molecule Smad-2P in spontaneous and instability-induced osteoarthritis:role in cartilage degradation, chondrogenesis and osteophyte formation [J]. Ann Rheum Dis, 2006, 65(11): 1414-21. doi: 10.1136/ard.2005.045971 [5] Muddasani P, Norman JC, Ellman M, et al. Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes [J]. J Biol Chem, 2007, 282(43): 31409-21. doi: 10.1074/jbc.M706508200 [6] Li X, Wu JF. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs).Recent Pat Anticancer Drug Discov 2010 [J]. 5(2): 109-41. doi: 10.2174/157489210790936234 [7] Baragi VM, Becher G, Bendele AM, et al. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis:Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models [J]. Arthritis Rheum, 2009, 60 (7): 2008-18. doi: 10.1002/art.v60:7 [8] Botter SM, Glasson SS, Hopkins B, et al. ADAMTS5-/-mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a Link between cartilage and subchondral bone changes [J]. Osteoarthritis Cartilage, 2009, 17(5): 636-45. doi: 10.1016/j.joca.2008.09.018 [9] Sahebjam S, Khokha R, Mort JS. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice[J]. Arthritis Rheum, 2007, 56(3): 905-9. doi: 10.1002/(ISSN)1529-0131 [10] Kashiwagi M, Tortorella M, Nagase H, et al. TIMP-3 is a potent inhibitor of aggrecanase 1(ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 2001 [J]. 276(16): 12501-4. doi: 10.1074/jbc.C000848200 [11] Troeberg L, Fushimi K, Khokha R, et al. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases[J]. FASEB J, 2008, 22(10): 3515-24. doi: 10.1096/fj.08-112680 [12] Chevalier X, Goupille P, Beaulieu AD, et al. Intra articular injection of anakinra in osteoarthritis of the knee:a multicenter, randomized, double-blind, placebo controlled study [J]. Arthritis Rheum, 2009, 61 (3): 344-352. doi: 10.1002/art.v61:3 [13] Bacconnier L, Jorgensen C, Fabre S. Erosive osteoarthritis of the hand: clinical experience with anakinra[J]. Ann Rheum Dis, 2009, 68(6): 1078-9. doi: 10.1136/ard.2008.094284 [14] Cohen SB, Proudman S, Kivitz AJ, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee[J]. Arthritis Res Ther, 2011, 13(4): R125. doi: 10.1186/ar3430 [15] Magnano MD, Chakravarty EF, Broudy CA, et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands [J]. J Rheumatol, 2007, 34(6): 1323-7. https://www.researchgate.net/publication/6315269_A_pilot_study_of_tumor_necrosis_factor_inhibition_in_erosiveinflammatory_osteoarthritis_of_the_hands [16] Verbruggen G, Wittoek R, Cruyssen BV. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification [J]. Ann Rheum Dis, 2012, 71(6): 891-8. doi: 10.1136/ard.2011.149849 [17] Mazzetti I, Grigolo B, Pulsatelli L, et al. Differential roles of nitric oxide and Oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis [J]. Clin Sci (Lond), 2001, 101 (6): 593-9. doi: 10.1042/cs1010593 [18] Studer RK, Levicoff E, Georgescu H, et al. Nitric oxide inhibits chondrocyte response to IGF-I:inhibition of IGF-IRbeta tyrosine phosphorylation[J]. Am J Physiol Cell Physiol, 2000, 279(4): C961-9. https://www.researchgate.net/publication/12319153_Nitric_oxide_inhibits_chondrocyte_response_to_IGF-I_Inhibition_of_IGF-IRb_tyrosine_phosphorylation [19] Yudoh K, Shishido K, Murayama H, et al. Water-soluble c60 fullerene prevents degeneration of articular cartilage in Osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development [J]. Arthritis Rheum, 2007, 56(10): 3307-18. doi: 10.1002/(ISSN)1529-0131 [20] Yudoh K, Nakamura H, Masuko-Hongo K, et al. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1alpha in articular chondrocytes:involvement of HIF-1alpha in the pathogenesis of osteoarthritis [J]. Arthritis Res Ther, 2005, 7(4): R904-14. doi: 10.1186/ar1765 [21] Fernandez P, Guillen MI, Gomar F, et al. Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes [J]. Biochem Pharmacol, 2003, 66(10): 2049-52. doi: 10.1016/S0006-2952(03)00543-4 [22] Guillen MI, Megias J, Gomar F, et al. Haem oxygenase-1 regulates catabolic and anabolic processes in osteoarthritic chondrocytes [J]. J Pathol, 2008, 214(4): 515-22. doi: 10.1002/path.2313/full [23] Clerigues V, Isabel Guillen M, Gomar FA. Haem oxygenase-1 counteracts the effects of interleukin-1 beta on inflammatory and senescence markers in cartilage-subchondral bone explants from osteoarthritic patients [J]. Clin Sci (Lond), 2012, 122(5/6): 239-50. https://www.researchgate.net/publication/51677655_Haem_oxygenase-1_counteracts_the_effects_of_interleukin-1b_on_inflammatory_and_senescence_markers_in_cartilage-subchondral_bone_explants_from_osteoarthritic_patients [24] Shortkroff S, Yates KE. Alteration of matrix glycosaminoglycans diminishes articular chondrocytes' response to a canonical Wnt signal [J]. Osteoarthritis Cartilage, 2007, 15(2): 147-54. doi: 10.1016/j.joca.2006.07.004 [25] Blom AB, Brockbank SM, van Lent PL, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis prominent role of Wnt-Induced signaling protein 1[J]. Arthritis Rheum, 2009, 60(2): 501-12. doi: 10.1002/art.v60:2 [26] Loughlin J, Dowling B, Chapman K, et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females[J]. Proc Natl Acad Sci USA, 2004, 101(26): 9757-62. doi: 10.1073/pnas.0403456101 [27] Lane NE, Nevitt MC, Lui LY, et al. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women[J]. Arthritis Rheum, 2007, 56(10): 3319-25. doi: 10.1002/(ISSN)1529-0131 [28] Ruiz-Heiland G, Horn A, Zerr P, et al. Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis[J]. Ann Rheum Dis, 2012, 71(3): 400-7. doi: 10.1136/ard.2010.148262 [29] Ng TC, Chiu KW, Rabie AB, et al. Repeated mechanical loading enhances the expression of Indian hedgehog in condylar cartilage [J]. Front Biosci, 2006, 11(11): 943-8. [30] Lin AC, Seeto BL, Bartoszko JM, et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis[J]. Nat Med, 2009, 15(12): 1U11-421. [31] Shakibaei M, John T, Schulze-Tanzil GA, et al. Suppression of NF-kappa B activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis [J]. Biochem Pharmacol, 2007, 73(9): 1434-45. doi: 10.1016/j.bcp.2007.01.005 [32] Chen LX, Lin L, Wang HJ, et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vectormediated NF-kappaBp65-specific siRNA[J]. Osteoarthritis Cartilage, 2008, 16(2): 174-84. doi: 10.1016/j.joca.2007.06.006 [33] Lauder SN, Carty SM, Carpenter CE, et al. Interleukin-1 beta induced activation of nuclear factor-kappa b can be inhibited by novel pharmacological agents in osteoarthritis[J]. Rheumatology (Oxford), 2007, 46(5): 752-8. doi: 10.1093/rheumatology/kel419 [34] Pelletier JP, Fernandes JC, Brunet J, et al. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis isassociated with a reduction in the development of structural changes[J]. Arthritis Rheum, 2003, 48 (6): 1582-93. doi: 10.1002/(ISSN)1529-0131 [35] Appleton C, Usmani SE, Mort JS. Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation [J]. Lab Invest, 2010, 90(1): 20-30. doi: 10.1038/labinvest.2009.111 [36] Prasadam I, Mao XZ, Shi W, et al. Combination of MEK-ERK inhibitor and hyaluronic acid has a synergistic effect on anti-hypertrophic and pro-chondrogenic activities in osteoarthritis treatment [J]. J Mol Med (Berl), 2013, 91(3): 369-80. doi: 10.1007/s00109-012-0953-5 -
点击查看大图
计量
- 文章访问数: 508
- HTML全文浏览量: 218
- PDF下载量: 7
- 被引次数: 0
下载:
